3/27
08:08 am
gmab
Genmab A/S (NASDAQ: GMAB) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $50.00 price target on the stock.
Low
Report
Genmab A/S (NASDAQ: GMAB) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $50.00 price target on the stock.
3/26
11:13 am
gmab
Genmab A/S (NASDAQ: GMAB) had its "underweight" rating re-affirmed by analysts at Morgan Stanley. They now have a $32.00 price target on the stock.
Low
Report
Genmab A/S (NASDAQ: GMAB) had its "underweight" rating re-affirmed by analysts at Morgan Stanley. They now have a $32.00 price target on the stock.
3/26
11:13 am
gmab
Genmab A/S (NASDAQ: GMAB) had its "underweight" rating re-affirmed by analysts at Morgan Stanley. They now have a $32.00 price target on the stock.
Low
Report
Genmab A/S (NASDAQ: GMAB) had its "underweight" rating re-affirmed by analysts at Morgan Stanley. They now have a $32.00 price target on the stock.
3/26
11:03 am
gmab
Rating for GMAB
Low
Report
Rating for GMAB
3/26
11:03 am
gmab
Rating for GMAB
Low
Report
Rating for GMAB
3/6
08:09 am
gmab
Genmab A/S (NASDAQ: GMAB) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $50.00 price target on the stock.
Low
Report
Genmab A/S (NASDAQ: GMAB) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $50.00 price target on the stock.
2/23
07:09 am
gmab
Genmab A/S (NASDAQ: GMAB) was upgraded by analysts at BMO Capital Markets from a "market perform" rating to an "outperform" rating. They now have a $48.00 price target on the stock, up previously from $46.00.
Low
Report
Genmab A/S (NASDAQ: GMAB) was upgraded by analysts at BMO Capital Markets from a "market perform" rating to an "outperform" rating. They now have a $48.00 price target on the stock, up previously from $46.00.
2/23
05:55 am
gmab
Rating for GMAB
Low
Report
Rating for GMAB
2/23
05:55 am
gmab
Rating for GMAB
Low
Report
Rating for GMAB
2/20
08:12 am
gmab
Genmab A/S (NASDAQ: GMAB) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $50.00 price target on the stock.
Low
Report
Genmab A/S (NASDAQ: GMAB) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $50.00 price target on the stock.
1/22
11:13 am
gmab
Genmab A/S (NASDAQ: GMAB) was downgraded by analysts at Citigroup Inc. from a "neutral" rating to a "sell" rating.
Low
Report
Genmab A/S (NASDAQ: GMAB) was downgraded by analysts at Citigroup Inc. from a "neutral" rating to a "sell" rating.